Pentoxifylline (Vasonit®) – a pathogenetic approach for the correction of cognitive impairment in cerebrovascular diseases. A review

Pentoxifylline (Vasonit®) – a pathogenetic approach for the correction of cognitive impairment in cerebrovascular diseases. A review

Cognitive impairment is one of the key manifestations of chronic cerebrovascular diseases. Among the factors contributing to their development are microcirculatory disturbances, changes in blood rheological properties, endothelial dysfunction and oxidative stress. This review is devoted to the analy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nataliya V. Titova, Ilya A. Putyatin
Format:	Article
Language:	Russian
Published:	ZAO "Consilium Medicum" 2024-12-01
Series:	Consilium Medicum
Subjects:	chronic cerebral ischemia cognitive impairment dementia microcirculation hemorheology pentoxifylline vasonit®
Online Access:	https://consilium.orscience.ru/2075-1753/article/viewFile/642902/158871
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Features of dissomnia and cognitive impairments in chronic cerebral ischemia due to diabetes mellitus type 2
by: Yu. I. Kotsenko
Published: (2024-09-01)

Pentoxifylline in Dogs With Osteoarthritis: Comparative Treatment and Efficacy Analysis With Meloxicam
by: Kurtuluş Parlak, et al.
Published: (2025-07-01)

Efficacy of Cellex in patients with mild cognitive impairment
by: B. A. Abusueva, et al.
Published: (2019-04-01)

Oxidative Mechanism of Peyronie’s Disease and Effectiveness of Pentoxifylline in the Therapeutic Management: A Narrative Review
by: Gianni Paulis, et al.
Published: (2025-02-01)

Cognitive impairments in cerebrovascular disease
by: A. Yu. Emelin
Published: (2014-12-01)

INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE
by: O. P. Dudarenko, et al.
Published: (2016-01-01)

Long-term carvedilol therapy in patients with stage II arterial hypertension
by: L. I. Markova, et al.
Published: (2006-06-01)

Protective Effect of Pentoxifylline on the Development of Acute Gastric Mucosal Injury in a Model of LPS-Induced Sepsis
by: Sergio D. Paredes, et al.
Published: (2024-12-01)

Association between pentoxifylline use and diabetic retinopathy in patients with type 2 diabetes mellitus and chronic kidney disease: A multi-institutional cohort study
by: Tzu-Yi Lin, et al.
Published: (2025-06-01)

Cognitive impairment in hypertension
by: Yu. A. Starchina, et al.
Published: (2021-02-01)

Effects of L-carnitine and pentoxifylline on long-term preservation of the human sperms: An experimental study
by: Elham Aliabadi, et al.
Published: (2025-01-01)

Very early remission and increased apoptosis with the use of Pentoxifylline in children with acute lymphoblastic leukemia
by: Violeta Salceda-Rivera, et al.
Published: (2024-10-01)

Effects of pentoxifylline on mouse oocytes maturation and qualityin vitro
by: Wu Junjiao, et al.
Published: (2025-03-01)

Immunomodulatory and Antioxidant Effects of Pentoxifylline and Other Therapeutic Agents in The Management of Myocardial Injury
by: Asmaa Saeed, et al.
Published: (2023-12-01)

Effect of pentoxifylline on endothelial dysfunction, oxidative stress and inflammatory markers in STEMI patients
by: Asmaa Saeed, et al.
Published: (2024-12-01)

HEMORHEOLOGICAL PROPERTIES OF THE 5-HT2A-ANTAGONIST OF THE 2-METHOXYPHENYL-IMIDAZOBENZIMIDAZOLE DERIVATIVE OF THE RU-31 COMPOUND AND CYPROHEPTADINE, IN COMPARISON WITH PENTHOXYPHYLLINE
by: D. S. Yakovlev, et al.
Published: (2021-03-01)

Necroptosis in vascular cognitive impairment: mechanisms and therapeutic potential
by: Shufei Wei, et al.
Published: (2025-06-01)

Pentoxifylline Enhances Sperm Quality, Reduces Oxidative Stress in Semen, and Decreases Sperm DNA Damage in Men with Asthenozoospermia Undergoing Assisted Reproductive Technology
by: Oumaima Ammar, et al.
Published: (2025-05-01)

Correlation Between Retinal Vascular Oxygen Saturation, Red Blood Cell Parameters and Hemorheology Parameters in Healthy Adults
by: Chang L, et al.
Published: (2025-08-01)

Exploring pentoxifylline as an alternative treatment for dexamethasone in diabetic patients with COVID-19: a randomized controlled trial
by: Mohsen Gholinataj Jelodar, et al.
Published: (2025-07-01)

Fibrinogen kao faktor rizika za ishemijsku bolest srca
by: Obradović Slobodan, et al.
Published: (2003-01-01)

Modern aspects of diagnosis and treatment of cognitive impairments (literature review)
by: A. B. Lokshina, et al.
Published: (2023-02-01)

Cerebral microbleeds: prevalence and relationship to clinical features in cognitive impairment with lewy body disease
by: Zhihong Ren, et al.
Published: (2025-04-01)

Glans ischemia in a 7-month-old boy who underwent correction of megaprepuce: case report and review of the literature
by: Susanne Kraske, et al.
Published: (2025-02-01)

Rational Analysis of the Utilization of Pentoxifylline in a Tertiary Hospital: Central Hospital Affiliated to Shandong First Medical University
by: Zheng Y, et al.
Published: (2025-07-01)

The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial
by: Amira Reda Muhammad Galal, et al.
Published: (2025-08-01)

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Falls in Persons with Cognitive Impairment—Incidence and Characteristics of the Fallers
by: Per G. Farup, et al.
Published: (2024-12-01)

Cognitive impairment without dementia: A current view of the problem
by: Yu. A. Starchina
Published: (2017-07-01)

Actovegin in the treatment of patients with cognitive impairments in the chronic cerebral ischemia
by: L. M. Boriskina
Published: (2015-12-01)

Cerebrovascular Disorders Associated with Ph-Negative Myeloproliferative Diseases
by: MM Tanashyan, et al.
Published: (2019-09-01)

Cognitive impairment in patients with Parkinson’s disease
by: I. A. Zhukova, et al.
Published: (2010-08-01)

Assessment of cognitive impairment in Tunisian hypertensive patients
by: Syrine Saidane, et al.
Published: (2025-04-01)

Facial aging, cognitive impairment, and dementia risk
by: Xinming Xu, et al.
Published: (2024-11-01)

Potential biomarkers for cerebral small vessel disease with cognitive impairment: a systematic review and meta-analysis
by: Libin Liao, et al.
Published: (2025-01-01)

Some pathogenetic aspects of experimental pneumococcal meningitis in acute period
by: V. V. Pilipenko, et al.
Published: (2014-09-01)

Elevated monocyte-to-high-density lipoprotein ratio is associated with increased risk of cognitive impairment and severe cerebral small vessel disease burden
by: Yueshan Zhao, et al.
Published: (2025-06-01)

AGE-RELATED CHANGES OF HEMORHEOLOGICAL STATUS
by: E. E. Bitkova, et al.
Published: (2016-03-01)

Machine learning applications in vascular neuroimaging for the diagnosis and prognosis of cognitive impairment and dementia: a systematic review and meta-analysis
by: Valerie Lohner, et al.
Published: (2025-08-01)

Eco-friendly RP-HPLC approach for simultaneously estimating the promising combination of pentoxifylline and simvastatin in therapeutic potential for breast cancer: Appraisal of greenness, whiteness, and Box–Behnken design
by: Mahgoub Samar M., et al.
Published: (2024-11-01)